185 related articles for article (PubMed ID: 22708928)
1. SULT1A1 rs9282861 polymorphism-a potential modifier of efficacy of the systemic adjuvant therapy in breast cancer?
Tengström M; Mannermaa A; Kosma VM; Hirvonen A; Kataja V
BMC Cancer; 2012 Jun; 12():257. PubMed ID: 22708928
[TBL] [Abstract][Full Text] [Related]
2. Association between sulfotransferase 1A1 genotype and survival of breast cancer patients receiving tamoxifen therapy.
Nowell S; Sweeney C; Winters M; Stone A; Lang NP; Hutchins LF; Kadlubar FF; Ambrosone CB
J Natl Cancer Inst; 2002 Nov; 94(21):1635-40. PubMed ID: 12419790
[TBL] [Abstract][Full Text] [Related]
3. MnSOD rs4880 and XPD rs13181 polymorphisms predict the survival of breast cancer patients treated with adjuvant tamoxifen.
Tengström M; Mannermaa A; Kosma VM; Soini Y; Hirvonen A; Kataja V
Acta Oncol; 2014 Jun; 53(6):769-75. PubMed ID: 24716840
[TBL] [Abstract][Full Text] [Related]
4. Association between SULT1A1 Arg213His (rs9282861) Polymorphism and Risk of Breast Cancer: A Systematic Review and Meta-Analysis.
Forat-Yazdi M; Jafari M; Kargar S; Abolbaghaei SM; Nasiri R; Farahnak S; Foroughi E; Neamatzadeh H
J Res Health Sci; 2017 Oct; 17(4):e00396. PubMed ID: 29233949
[TBL] [Abstract][Full Text] [Related]
5. Genotypic and allelic frequencies of SULT1A1 polymorphisms in women receiving adjuvant tamoxifen therapy.
Grabinski JL; Smith LS; Chisholm GB; Drengler R; Rodriguez GI; Lang AS; Kalter SP; Garner AM; Fichtel LM; Hollsten J; Pollock BH; Kuhn JG
Breast Cancer Res Treat; 2006 Jan; 95(1):13-6. PubMed ID: 16317586
[TBL] [Abstract][Full Text] [Related]
6. Genotype of metabolic enzymes and the benefit of tamoxifen in postmenopausal breast cancer patients.
Wegman P; Vainikka L; Stål O; Nordenskjöld B; Skoog L; Rutqvist LE; Wingren S
Breast Cancer Res; 2005; 7(3):R284-90. PubMed ID: 15987423
[TBL] [Abstract][Full Text] [Related]
7. Genetic variants of CYP3A5, CYP2D6, SULT1A1, UGT2B15 and tamoxifen response in postmenopausal patients with breast cancer.
Wegman P; Elingarami S; Carstensen J; Stål O; Nordenskjöld B; Wingren S
Breast Cancer Res; 2007; 9(1):R7. PubMed ID: 17244352
[TBL] [Abstract][Full Text] [Related]
8. Genetic polymorphisms of 3'-untranslated region of SULT1A1 and their impact on tamoxifen metabolism and efficacy.
Sanchez-Spitman AB; Dezentjé VO; Swen JJ; Moes DJAR; Gelderblom H; Guchelaar HJ
Breast Cancer Res Treat; 2018 Nov; 172(2):401-411. PubMed ID: 30120701
[TBL] [Abstract][Full Text] [Related]
9. CYP2D6 gene variants: association with breast cancer specific survival in a cohort of breast cancer patients from the United Kingdom treated with adjuvant tamoxifen.
Abraham JE; Maranian MJ; Driver KE; Platte R; Kalmyrzaev B; Baynes C; Luccarini C; Shah M; Ingle S; Greenberg D; Earl HM; Dunning AM; Pharoah PD; Caldas C
Breast Cancer Res; 2010; 12(4):R64. PubMed ID: 20731819
[TBL] [Abstract][Full Text] [Related]
10. The Effect of Polymorphism in UGT1A4 on Clinical Outcomes of Adjuvant Tamoxifen Therapy for Patients With Breast Cancer in China.
Lan B; Ma F; Han M; Chen S; Wang W; Li Q; Fan Y; Luo Y; Cai R; Wang J; Yuan P; Zhang P; Li Q; Xu B
Clin Breast Cancer; 2019 Apr; 19(2):e370-e375. PubMed ID: 30630678
[TBL] [Abstract][Full Text] [Related]
11. Association of genetic variation in tamoxifen-metabolizing enzymes with overall survival and recurrence of disease in breast cancer patients.
Nowell SA; Ahn J; Rae JM; Scheys JO; Trovato A; Sweeney C; MacLeod SL; Kadlubar FF; Ambrosone CB
Breast Cancer Res Treat; 2005 Jun; 91(3):249-58. PubMed ID: 15952058
[TBL] [Abstract][Full Text] [Related]
12. Direct comparisons of adjuvant endocrine therapy, chemotherapy, and chemoendocrine therapy for operable breast cancer patients stratified by estrogen receptor and menopausal status.
Nomura Y; Shirouzu M; Takayama T
Breast Cancer Res Treat; 1998 May; 49(1):51-60. PubMed ID: 9694611
[TBL] [Abstract][Full Text] [Related]
13. Optimal adjuvant endocrine treatment of ER+/HER2+ breast cancer patients by age at diagnosis: A population-based cohort study.
Dackus GMHE; Jóźwiak K; Sonke GS; van der Wall E; van Diest PJ; Hauptmann M; Siesling S; Linn SC
Eur J Cancer; 2018 Feb; 90():92-101. PubMed ID: 29274928
[TBL] [Abstract][Full Text] [Related]
14. The relationship between the CYP2D6 polymorphisms and tamoxifen efficacy in adjuvant endocrine therapy of breast cancer patients in Chinese Han population.
Lan B; Ma F; Zhai X; Li Q; Chen S; Wang J; Fan Y; Luo Y; Cai R; Yuan P; Zhang P; Li Q; Xu B
Int J Cancer; 2018 Jul; 143(1):184-189. PubMed ID: 29396856
[TBL] [Abstract][Full Text] [Related]
15. SULT1A1, CYP2C19 and disease-free survival in early breast cancer patients receiving tamoxifen.
Moyer AM; Suman VJ; Weinshilboum RM; Avula R; Black JL; Safgren SL; Kuffel MJ; Ames MM; Ingle JN; Goetz MP
Pharmacogenomics; 2011 Nov; 12(11):1535-43. PubMed ID: 21961651
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant sequencing of tamoxifen and anastrozole is superior to tamoxifen alone in postmenopausal women with low proliferating breast cancer.
Bago-Horvath Z; Rudas M; Dubsky P; Jakesz R; Singer CF; Kemmerling R; Greil R; Jelen A; Böhm G; Jasarevic Z; Haid A; Gruber C; Pöstlberger S; Filipits M; Gnant M;
Clin Cancer Res; 2011 Dec; 17(24):7828-34. PubMed ID: 21998336
[TBL] [Abstract][Full Text] [Related]
17. Impact of UGT2B7 His268Tyr polymorphism on the outcome of adjuvant epirubicin treatment in breast cancer.
Parmar S; Stingl JC; Huber-Wechselberger A; Kainz A; Renner W; Langsenlehner U; Krippl P; Brockmöller J; Haschke-Becher E
Breast Cancer Res; 2011 Jun; 13(3):R57. PubMed ID: 21658222
[TBL] [Abstract][Full Text] [Related]
18. SULT1A1 genotype, active and passive smoking, and breast cancer risk by age 50 years in a German case-control study.
Lilla C; Risch A; Kropp S; Chang-Claude J
Breast Cancer Res; 2005; 7(2):R229-37. PubMed ID: 15743503
[TBL] [Abstract][Full Text] [Related]
19. Breast cancer patients with estrogen receptor-negative/progesterone receptor-positive tumors: being younger and getting less benefit from adjuvant tamoxifen treatment.
Yu KD; Di GH; Wu J; Lu JS; Shen KW; Liu GY; Shen ZZ; Shao ZM
J Cancer Res Clin Oncol; 2008 Dec; 134(12):1347-54. PubMed ID: 18488249
[TBL] [Abstract][Full Text] [Related]
20. Effects of CYP2D6 and SULT1A1 genotypes including SULT1A1 gene copy number on tamoxifen metabolism.
Gjerde J; Hauglid M; Breilid H; Lundgren S; Varhaug JE; Kisanga ER; Mellgren G; Steen VM; Lien EA
Ann Oncol; 2008 Jan; 19(1):56-61. PubMed ID: 17947222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
